Icon

Consensi - (2.5 mg/200 mg, 5 mg/200 mg, 10 mg/200 mg; Tablet)

Amlodipine Besylate and Celecoxib Coeptis Pharma
2.5 mg/200 mg, 5 mg/200 mg, 10 mg/200 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
Consensi is a combination of amlodipine besylate, a calcium channel blocker, and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), indicated for patients for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate.
Yes
***** ** ***. ***** ***** * **** ** ** ******* '***, '***, '*** *** '*** *** *** *********. ** ****** **** **** ***** ****** ** ***** ****. ** *** *** **, **** ***** ******* ***** ****** ******* *** **** ** ****** *******.. *** ******** **** ***** *** **** ******* ******** ** **** ** ******* ****** ***** ** ****** *******’* *.*. ************ *******.
Consensi Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
***** ******* *** ********* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* ***** **, **** ******* **** *** ****** ***** ****
  1. *** *, **** : ***** ******** ***** ****** ***** **'* **** ** ****** ** ******* '*** *** '***
  2. *** **, **** : ***** ****** ***** * **** ******* ***** ** ******* '*** *** '***
  3. *** **, **** : ** *** ***** ******* ***** ****** *** ******* *** **** ** ****** *******.
  4. *** **, **** : ***** ******* **** ****** *******(***** ******)-******* ****** ** *********** *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.